Abstract
Mice were exposed to 1 month of spaceflight on Russian biosatellite BION-M1 to determine its effect on the expression of key genes in the brain dopamine (DA) and serotonin (5-HT) systems. Spaceflight decreased the expression of crucial genes involved in DA synthesis and degradation, as well as the D1 receptor. However, spaceflight failed to alter the expression of tryptophan hydroxylase-2, 5-HT transporter, 5-HT1A, and 5-HT3 receptor genes, though it reduced 5-HT2A receptor gene expression in the hypothalamus. We revealed risk DA and 5-HT neurogenes for long-term spaceflight for the first time, as well as microgravity-responsive genes (tyrosine hydroxylase, catechol-O-methyltransferase, and D1 receptor in the nigrostriatal system; D1 and 5-HT2A receptors in the hypothalamus; and monoamine oxidase A (MAO A) in the frontal cortex). Decreased genetic control of the DA system may contribute to the spaceflight-induced locomotor impairment and dyskinesia described for both humans and rats.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
The effect of altered gravitation on the brain is a basic problem encountered with spaceflight. Living organisms on Earth evolved in a relatively constant gravitational environment, so the condition of microgravity is non-physiological. The milestone problem is the effect of long-term spaceflight on brain function. Taking into account the pivotal role of brain neurotransmitters in the regulation of mood, emotionality, and behavior, the effect of spaceflight on brain neurotransmitters arouses keen interest.
Serotonin (5-HT) is a classic neurotransmitter involved in the regulation of different kinds of behavior [1], sleep [2, 3], and the stress response [4]. Dysfunction of the brain 5-HT system is implicated in the mechanisms underlying severe neuropsychiatric disorders, including aggression, depression, and suicide [5–7], as well as schizophrenia [8–10], anxiety [11], substance abuse [12, 13] and drug addiction [14, 15], and Parkinson’s [16] and Alzheimer’s [17] diseases.
Brain dopamine (DA) represents another neurotransmitter that attracts attention given its well-defined role in the regulation of movement and muscle tone [18] and its implication in exercise-induced central fatigue [19], tardive dyskinesia [20], Parkinson’s [21, 22] and Alzheimer’s [23–25] diseases, major depression [26–28], and schizophrenia [29–32].
Data on the effect of actual spaceflight on the brain 5-HT and DA systems are scarce and limited to the hypothalamic area. The levels of 5-HT and DA and the activity of the main enzymes in DA metabolism, tyrosine hydroxylase (TH) and monoamine oxidase (MAO), have been determined in the hypothalamus. The functional significance ofin the hypothalamus. The functional significance of of rats after 19.5 days of spaceflight on board the biosatellites Cosmos 782 and 936 [33, 34]. No significant changes were found in the DA level or TH and MAO activity. In the space experiment Cosmos 1129, the concentrations of norepinephrine, DA, and 5-HT were studied in isolated nuclei from the rat hypothalamus after 18.5 days of spaceflight. A reduced norepinephrine level was found in some hypothalamic nuclei, but no significant changes in DA levels were revealed [33]. The concentration of 5-HT was unchanged in the majority of hypothalamic nuclei, but an increase was found in supraoptic nuclei and a decrease in paraventricular nuclei. Long-term spaceflight and weightlessness were suggested to not represent a stressogenic factor with respect to the 5-HT system in the hypothalamus [34]. Notwithstanding the limitations of these data, these results decreased interest to the DA and 5-HT systems, and the effect of long-term spaceflight on the main central regulators of emotions, movement, and behavior remained unknown.
The aim of the present study was to evaluate the effect of actual long-term spaceflight on the expression of key genes in the DA and 5-HT systems. The candidate genes include (1) key genes in DA synthesis (TH) and degradation (catechol-O-methyltransferase (COMT)) as well as dopamine transporter (DAT), dopamine D1 and D2 receptors; (2) 5-HT transporter (5-HTT), 5-HT1A, 5-HT2A, and 5-HT3 receptor genes and pivotal gene involved in 5-HT synthesis in the brain (tryptophan hydroxylase-2 (Tph-2)); and (3) principal genes involved in 5-HT and DA degradation: MAO A and MAO B.
Materials and Methods
Animals
The experiments were carried out on adult (about 4 months old at the beginning of the experiments) weighted about 25 ± 2-g male mice of C57BL/6 inbred strain. Forty-five mice were launched into space for 30 days on the Bion-M1 spacecraft, part of the Bion series of Russian space missions. The animal-carrying space capsule was launched into orbit on April 19, 2013 and returned to Earth on May 19, 2013.
The spaceflight and shuttle cabin control mice were kept three per cage in special chambers (shuttle cabins) described in detail by Sychev and coauthors [35] in a natural light-dark cycle (12 h light and 12 h dark). The mice of spaceflight and shuttle cabin control groups have access to paste-like food with 76–78 % water content ad libitum. The temperature in the chambers was 21 °C; relative humidity was 61 %. After spaceflight, mice did not differ significantly from control groups in body weight. For details see [36].
The vivarium control mice were kept three per cage in standard cages in a natural light-dark cycle (12 h light and 12 h dark). The mice have access to standard granulated food and water ad libitum. The room temperature was about 23 °C; relative humidity was about 50 %.
The mice were sacrificed by manual cervical dislocation followed by decapitation within 6 h after landing. The frontal cortex, visual cortex, hypothalamus, hippocampus, striatum, substantia nigra, and raphe nucleus area of the midbrain were dissected on ice and frozen in liquid nitrogen. The brain structures were dissected by the same researcher based on a mouse brain atlas [37]. For the frontal cortex, the following coordinates were used: anterior-posterior (AP) +1.6 to +2.8, lateral (L) −2 to +2; the thickness of the slice was about 1.5 mm. Visual cortex coordinates were AP −3.0 to −4.0, L −1 to +1; the thickness of the slice was about 1.5 mm. The hypothalamus was dissected using coordinates AP +0.3 to −2.9, L −1 to +1, dorsal-ventral (DV) 3.2 to 5.8. Both hippocampi were dissected from AP −0.8 to AP −2.9. Striatum coordinates were AP +1.3 to −1.0, L −2.4 to −3.8 and +2.4 to +3.8, DV 2.4 to 3.8. For the midbrain, a cranial section was made in front of the superior colliculi (AP −3) and a caudal section in front of the fossa rhomboidalis (AP −7.3), and then, the colliculi were removed. The substantia nigra was dissected using coordinates: AP −2.7 to −3.4, L −1.2 to −2.0 and +1.2 to +2.0, DV 3.6 to 4.4.
The same brain structures were dissected from mice of the ground control group. The brain structures from six mice from the spaceflight group and eight mice from the ground control group were transferred to the laboratory of Behavioral Neurogenomics, Novosibirsk, for further studies.
To differentiate the effect of microgravity from the effect of stress on the expression of the investigated genes, we performed a special series of experiments on seven mice that spent 1 month in the same capsules that were used for spaceflight but under conditions of gravitation (shuttle cabin control). A group of intact mice (n = 7) was used as an additional control for the cabin control mice. The mice were sacrificed by manual cervical dislocation followed by decapitation and the same brain structures were dissected as described above.
All experimental procedures were in compliance with the Guidelines for the Use of Animals in Neuroscience Research, 1992. All efforts were made to minimize the number of animals used and their suffering.
RT-PCR
Total RNA was extracted using TRIzol (Bio-Rad, USA) according to the manufacturer’s instructions, treated with RNA-free DNAse (Promega, USA), and diluted to 0.125 μg/μl with DEPC-treated water. One microgram of total RNA was taken for complementary DNA (cDNA) synthesis with a random hexanucleotide mixture [38]. Genomic DNA contamination of the cDNA samples was tested using PCR with primers specific for the mouse tryptophan hydroxylase-1 gene [39, 40]. The concentration of genomic DNA in the cDNA samples did not exceed 30 copies per microliter. The number of copies of DNA-dependent RNA polymerase II (rPol II), TH, MAO A, MAO B, COMT, D1, D2 receptors, DAT, 5-HT1A, 5-HT2A, and 5-HT3 receptors, Tph-2, and 5-HTT cDNA was evaluated by real-time quantitative PCR using selective primers (Table 1), SYBR Green I fluorescence detection (R-414 Master mix, Syntol, Moscow, Russia), and genomic DNA extracted from the livers of male C57BL/6 J mice as the external standard (200 copies per nanogram of genomic DNA). We used 50, 100, 200, 400, 800, 1,600, 3,200, and 6,400 copies of genomic DNA as external standards for all studied genes. Reagent controls were carried out under the same conditions but without the template. Gene expression was evaluated as the number of cDNA copies with respect to 100 copies of rPol II cDNA [38–40]. Melting curve analysis was performed at the end of each run for each primer pair, allowing us to control amplification specificity.
Statistical Analysis
The results were presented as mean ± SEM and compared using one-way ANOVA followed by a post hoc Fisher test.
Results
Spaceflight considerably affected the expression of key genes of the brain dopaminergic and serotonergic systems. The expression of D1 receptor was significantly lower in the hypothalamus (F 1,11 = 4.7; p < 0.05) and striatum (F 1,10 = 6.2; p < 0.05) of spaceflight mice compared to ground control (Fig. 1a). At the same time, spaceflight failed to alter D1 receptor gene expression in other investigated brain structures.
Spaceflight significantly reduced the expression of the gene encoding key enzyme for DA biosynthesis—TH (F 1,11 = 9.9; p < 0.05) in substantia (s.) nigra but not in the midbrain area (F 1,12 = 2.9; p > 0.05) (Fig. 2) and the expression of the COMT gene in the striatum (F 1,11 = 4.9; p < 0.05) (Fig. 1c). Some increase in COMT gene expression in the hippocampus of spaceflight mice was shown, however, it was below the significance threshold (F 1,12 = 3.9; p = 0.07). Expression of the COMT gene in other five investigated brain structures was unaltered.
Spaceflight reduced the expression of genes encoding both main enzymes for DA and 5-HT catabolism. MAO A gene expression was significantly decreased in the frontal cortex (F 1,11 = 5.7; p < 0.05) (Fig. 3a) and in the striatum (F 1,9 = 4.7; p = 0.05). The reduction of MAO B gene expression in the raphe nucleus area of the midbrain (F 1,12 = 4.5; p < 0.05) was shown (Fig. 3c). Spaceflight failed to alter the expression of MAO A and MAO B in other investigated brain structures.
The expression of genes encoding D2 receptor and DAT in all investigated brain structures of spaceflight mice was unaltered (Fig. 1b, d).
Spaceflight considerably decreased the expression of 5-HT2A receptor in the hypothalamus (F 1,12 = 4.9; p < 0.05) compared to control mice (Fig. 4b). The reduction of 5-HT2A receptor gene expression in the striatum was below the significance threshold (F 1,11 = 3.9; p = 0.08). The increase of 5-HT3 receptor gene expression in spaceflight mice was observed as tendency (F 1,12 = 3.9; p = 0.07) only in the raphe nucleus area of the midbrain (Fig. 4c).
Spaceflight failed to cause any changes in 5-HT1A receptor gene expression in all seven investigated brain structures (Fig. 4a). There were no changes in the expression of gene encoding the key enzyme for 5-HT biosynthesis in the brain, Tph-2, and 5-HTT in the raphe nucleus area of the midbrain of spaceflight mice (Fig. 4d, e).
To elucidate the role of stress in the inhibitory effect of the spaceflight on some genes, we used shuttle cabin (the same environment, normal gravitation) and ground control groups to investigate the expression of response to spaceflight genes. It was found that stress considerably reduced the expression of MAO B in the midbrain (F 1,12 = 21.4; p < 0.001) (Fig. 3d) and MAO A in the striatum (F 1,12 = 35.4; p < 0.001) (Fig. 3b) that coincides with the results for the spaceflight group (Fig. 3a, c).
At the same time, the expression of other response to spaceflight genes (TH in s. nigra, COMT in the striatum, D1 receptor in the striatum and hypothalamus, and 5-HT2A receptor in the hypothalamus) in the mice of shuttle cabin control group was not significantly different from the mice of ground control group (Figs. 5 and 6).
Discussion
The 5-HT and DA brain systems responded to actual spaceflight with decreased gene expression in some brain regions. Significant changes were found in the genetic control of the DA system. Long-term spaceflight decreased the expression of genes encoding enzymes for both DA biosynthesis and degradation. Reduced expression of the gene encoding a key enzyme in DA biosynthesis in the main area of DA synthesis in the brain, the substantia nigra, was shown after spaceflight. DA catabolism in the brain occurs via two pathways: oxidative deamination by MAO A and MAO B and O-methylation by COMT. MAO B expression in the midbrain and MAO A and COMT expression in the striatum were decreased after spaceflight. Taken together with the decreased expression of dopamine D1 receptor in the striatum and hypothalamus, our data indicate a substantial attenuating effect of long-term spaceflight on the genetic control of the brain DA system. Importantly, the changes were found in the nigrostriatal DA system, which is considered the center of sensorimotor integration [41], regulating the tone and contraction of skeletal muscle [18].
One of the major problems of space travel is the deleterious effect of microgravity on bones [42] and skeletal muscle [43, 44]. Microgravity leads to a loss of calcium from weight-bearing bones and an increased risk of fractures and premature osteoporosis in later life [42]. Studies of the effect of microgravity on both rats and humans have demonstrated severe atonia, impaired postural and locomotor activity, rapid loss of muscle and fiber mass, reduced peak power, muscle atrophy, and increased rate of fatigue [45–49]. Our data suggest that damaging effects of space travel on skeletal muscle, as well as increased rates of fatigue, can be attributed not only to local changes in the substrates for muscle fiber metabolism and defective microcirculation following spaceflight [47, 50] but also to decreased nigrostriatal dopaminergic control. At the same time, one cannot exclude that muscle structure changes could lead to alteration in the brain DA system.
A more limited effect of actual spaceflight was found on the genetic control of the 5-HT system. In contrast to the DA system, no changes were found in the expression of genes encoding the main regulators of 5-HT functional activity: Tph-2, 5-HTT, and 5-HT1A receptors. Importantly, Tph-2 is a rate-limiting enzyme in 5-HT synthesis and the only really specific enzyme in 5-HT brain metabolism. The 5-HT1A receptor is a key player in the autoregulation of the 5-HT brain system [51]. Spaceflight did not cause any significant changes in the expression of the 5-HT3 receptor gene. The only specific 5-HT system change was found in the gene encoding the 5-HT2A receptor; long-term spaceflight decreased the expression of 5-HT2A receptor gene in the hypothalamus. The functional significance of this effect of spaceflight is not clear, but taking into account that 5-HT2A receptors are implicated in the regulation of a wide range of physiological functions, including sleep, cognition, and memory [52, 53], the 5-HT2A receptor is worthy of future investigations.
Along with DA, MAO catalyzes the oxidative deamination of 5-HT. MAO A has a higher affinity for 5-HT than MAO B and is considered the principle enzyme of 5-HT degradation. Therefore, the decreased MAO A expression in the frontal cortex and striatum can also be attributed to the brain 5-HT system.
A series of additional control mice spent 1 month on Earth in a shuttle cabin and exposed to the same experimental environment with the exception of microgravity, allowing us to reveal the changes in neurotransmitters produced by the lack of gravitation. The data attribute the decrease in the expression of key genes in the DA system, serotonergic 5-HT2A receptor gene in the hypothalamus and MAO A in the frontal cortex, to the effect of microgravity. In contrast, the changes in MAO B in the midbrain and MAO A in the striatum seem to be associated with the effect of environmental stress.
Our results elucidated DA and 5-HT genes and brain areas that are sensitive and resistant to spaceflight. In contrast to the decreased expression of MAO A, COMT, and D1 receptor genes in the striatum and 5-HT2A and D1 receptor genes in the hypothalamus, no changes were found in the expression of 5-HT or DA gene families in the hippocampus. Locus minoris resistentiae includes genes involved in the regulation of DA metabolism as well as the D1 receptor. The implication of the DA system in the regulation of movement and muscle tone suggests that decreased genetic control of the nigrostriatal DA system may contribute to the deleterious effect of spaceflight on skeletal muscle tone and locomotor activity described for both rats and humans.
References
Jacobs BL, Fornal CA (1995) Serotonin and behavior. A general hypothesis. In: Bloom FE, Kupfer DJ (eds) Psychopharmacology: the fourth generation of progress. Raven Press, New York, pp 461–469
Jouvet M (1967) Neurophysiology of the states of sleep. Physiol Rev 47:117–177
Jouvet M (1969) Biogenic amines and the states of sleep. Science 163:32–41
Joels M, Baram TZ (2009) The neuro-symphony of stress. Nat Rev Neurosci 10:459–466
Popova NK (2006) From genes to aggressive behavior: the role of serotonergic system. Bioessays 28:495–503
Linnoila VM, Virkkunen M (1992) Aggression, suicidality, and serotonin. J Clin Psychiatry 53(Suppl):46–51
Arango V, Huang YY, Underwood MD, Mann JJ (2003) Genetics of the serotonergic system in suicidal behavior. J Psychiatr Res 37:375–386
Bantick RA, Deakin JF, Grasby PM (2001) The 5-HT1A receptor in schizophrenia: a promising target for novel atypical neuroleptics? J Psychopharmacol 15:37–46
Meltzer HY, Sumiyoshi T (2008) Does stimulation of 5-HT(1A) receptors improve cognition in schizophrenia? Behav Brain Res 195:98–102
Meltzer HY (1999) The role of serotonin in antipsychotic drug action. Neuropsychopharmacology 21:106S–115S
Overstreet DH, Commissaris RC, De La Garza R 2nd, File SE, Knapp DJ, Seiden LS (2003) Involvement of 5-HT1A receptors in animal tests of anxiety and depression: evidence from genetic models. Stress 6:101–110
Kelai S, Renoir T, Chouchana L, Saurini F, Hanoun N, Hamon M, Lanfumey L (2008) Chronic voluntary ethanol intake hypersensitizes 5-HT(1A) autoreceptors in C57BL/6 J mice. J Neurochem 107:1660–1670
Popova NK, Ivanova EA (2002) 5-HT(1A) receptor antagonist p-MPPI attenuates acute ethanol effects in mice and rats. Neurosci Lett 322:1–4
Filip M, Alenina N, Bader M, Przegalinski E (2010) Behavioral evidence for the significance of serotoninergic (5-HT) receptors in cocaine addiction. Addict Biol 15:227–249
Muller CP, Huston JP (2006) Determining the region-specific contributions of 5-HT receptors to the psychostimulant effects of cocaine. Trends Pharmacol Sci 27:105–112
Tomiyama M, Kimura T, Maeda T, Kannari K, Matsunaga M, Baba M (2005) A serotonin 5-HT1A receptor agonist prevents behavioral sensitization to L-DOPA in a rodent model of Parkinson’s disease. Neurosci Res 52:185–194
Lai MK, Tsang SW, Francis PT, Esiri MM, Keene J, Hope T, Chen CP (2003) Reduced serotonin 5-HT1A receptor binding in the temporal cortex correlates with aggressive behavior in Alzheimer disease. Brain Res 974:82–87
Korchounov A, Meyer MF, Krasnianski M (2010) Postsynaptic nigrostriatal dopamine receptors and their role in movement regulation. J Neural Transm 117:1359–1369
Foley TE, Fleshner M (2008) Neuroplasticity of dopamine circuits after exercise: implications for central fatigue. Neuromol Med 10:67–80
Rana AQ, Chaudry ZM, Blanchet PJ (2013) New and emerging treatments for symptomatic tardive dyskinesia. Drug Des Dev Ther 7:1329–1340
Poletti M, Bonuccelli U (2013) Acute and chronic cognitive effects of levodopa and dopamine agonists on patients with Parkinson’s disease: a review. Ther Adv Psychopharmacol 3:101–113
Antonelli F, Strafella AP (2014) Behavioral disorders in Parkinson’s disease: the role of dopamine. Parkinsonism Relat Disord 20(Suppl 1):S10–S12
McCormick AV, Wheeler JM, Guthrie CR, Liachko NF, Kraemer BC (2013) Dopamine D2 receptor antagonism suppresses tau aggregation and neurotoxicity. Biol Psychiatry 73:464–471
Guzman-Ramos K, Moreno-Castilla P, Castro-Cruz M, McGaugh JL, Martinez-Coria H, LaFerla FM, Bermudez-Rattoni F (2012) Restoration of dopamine release deficits during object recognition memory acquisition attenuates cognitive impairment in a triple transgenic mice model of Alzheimer’s disease. Learn Mem 19:453–460
Mitchell RA, Herrmann N, Lanctot KL (2011) The role of dopamine in symptoms and treatment of apathy in Alzheimer’s disease. CNS Neurosci Ther 17:411–427
Camardese G, Di Giuda D, Di Nicola M, Cocciolillo F, Giordano A, Janiri L, Guglielmo R (2014) Imaging studies on dopamine transporter and depression: a review of literature and suggestions for future research. J Psychiatr Res 51C:7–18
Lattanzi L, Dell'Osso L, Cassano P, Pini S, Rucci P, Houck PR, Gemignani A, Battistini G, Bassi A, Abelli M, Cassano GB (2002) Pramipexole in treatment-resistant depression: a 16-week naturalistic study. Bipolar Disord 4:307–314
D'Aquila PS, Collu M, Gessa GL, Serra G (2000) The role of dopamine in the mechanism of action of antidepressant drugs. Eur J Pharmacol 405:365–373
Perez SM, Chen L, Lodge DJ (2014) Alterations in dopamine system function across the estrous cycle of the MAM rodent model of schizophrenia. Psychoneuroendocrinology 47:88–97
Muller UJ, Teegen B, Probst C, Bernstein HG, Busse S, Bogerts B, Schiltz K, Stoecker W, Steiner J (2014) Absence of dopamine receptor serum autoantibodies in schizophrenia patients with an acute disease episode. Schizophr Res
Al-Asmary S, Kadasah S, Arfin M, Tariq M, Al-Asmari A (2014) Genetic association of catechol-O-methyltransferase val(158)met polymorphism in Saudi schizophrenia patients. Genet Mol Res 13:3079–3088
Yao J, Ding M, Xing J, Xuan J, Pang H, Pan Y, Wang B (2014) Genetic association between the dopamine D1-receptor gene and paranoid schizophrenia in a northern Han Chinese population. Neuropsychiatr Dis Treat 10:645–652
Kvetnansky R, Culman J, Serova LV, Tigranjan RA, Torda T, Macho L (1983) Catecholamines and their enzymes in discrete brain areas of rats after space flight on biosatellites Cosmos. Acta Astronaut 10:295–300
Culman J, Kvetnansky T, Serova LV, Tigranjan RA, Macho L (1985) Serotonin in individual hypothalamic nuclei of rats after space flight on biosatellite Cosmos 1129. Acta Astronaut 12:373–376
Sychev VN, Ilyin ЕА, Yarmanova ЕN, Rakov DV, Ushakov IB, Kirilin АN, Orlov ОI, Grigoriev АI (2014) The BION-M1 project: overview and first results. Aviakosmicheskaya I Ekologicheskaya Meditsina (Russia) 48:7–14
Andreev-Andrievsky АА, Shenkman BS, Popova АS, Dolguikh ОN, Anokhin KV, Soldatov PE, Ilyin ЕА, Sychev VN (2014) Experimental studies with mice on the program of the biosatellite BION-M1 mission. Aviakosmicheskaya I Ekologicheskaya Meditsina (Russia) 48:14–27
Slotnick BM, Leonard CM (1975) A stereotaxic atlas of the albino mouse forebrain. U.S. Dept. of Health, Education and Welfare, Rockville, 174 p
Kulikov AV, Naumenko VS, Voronova IP, Tikhonova MA, Popova NK (2005) Quantitative RT-PCR assay of 5-HT1A and 5-HT2A serotonin receptor mRNAs using genomic DNA as an external standard. J Neurosci Methods 141:97–101
Naumenko VS, Kulikov AV (2006) Quantitative assay of 5-HT(1A) serotonin receptor gene expression in the brain. Mol Biol (Mosk) 40:37–44
Naumenko VS, Osipova DV, Kostina EV, Kulikov AV (2008) Utilization of a two-standard system in real-time PCR for quantification of gene expression in the brain. J Neurosci Methods 170:197–203
Onn SP, West AR, Grace AA (2000) Dopamine-mediated regulation of striatal neuronal and network interactions. Trends Neurosci 23:S48–S56
Droppert PM (1990) The effects of microgravity on the skeletal system–a review. J Br Interplanet Soc 43:19–24
LeBlanc A, Lin C, Shackelford L, Sinitsyn V, Evans H, Belichenko O, Schenkman B, Kozlovskaya I, Oganov V, Bakulin A, Hedrick T, Feeback D (2000) Muscle volume, MRI relaxation times (T2), and body composition after spaceflight. J Appl Physiol (1985) 89:2158–2164
Shenkman BS, Belozerova IN, Lee P, Nemirovskaya TL, Kozlovskaya IB (2003) Effects of weightlessness and movement restriction on the structure and metabolism of the soleus muscle in monkeys after space flight. Neurosci Behav Physiol 33:717–722
Schuenke MD, Reed DW, Kraemer WJ, Staron RS, Volek JS, Hymer WC, Gordon S, Perry Koziris L (2009) Effects of 14 days of microgravity on fast hindlimb and diaphragm muscles of the rat. Eur J Appl Physiol 106:885–892
Roy RR, Baldwin KM, Edgerton VR (1996) Response of the neuromuscular unit to spaceflight: what has been learned from the rat model. Exerc Sport Sci Rev 24:399–425
Fitts RH, Riley DR, Widrick JJ (2001) Functional and structural adaptations of skeletal muscle to microgravity. J Exp Biol 204:3201–3208
Kozlovskaya IB, Kreidich Yu V, Oganov VS, Koserenko OP (1981) Pathophysiology of motor functions in prolonged manned space flights. Acta Astronaut 8:1059–1072
Layne CS, Mulavara AP, McDonald PV, Pruett CJ, Kozlovskaya IB, Bloomberg JJ (2001) Effect of long-duration spaceflight on postural control during self-generated perturbations. J Appl Physiol (1985) 90:997–1006
Riley DA, Ellis S, Giometti CS, Hoh JF, Ilyina-Kakueva EI, Oganov VS, Slocum GR, Bain JL, Sedlak FR (1992) Muscle sarcomere lesions and thrombosis after spaceflight and suspension unloading. J Appl Physiol (1985) 73:33S–43S
Popova NK, Naumenko VS (2013) 5-HT1A receptor as a key player in the brain 5-HT system. Rev Neurosci 24:191–204
Williams GV, Rao SG, Goldman-Rakic PS (2002) The physiological role of 5-HT2A receptors in working memory. J Neurosci 22:2843–2854
Wilson S, Argyropoulos S (2005) Antidepressants and sleep: a qualitative review of the literature. Drugs 65:927–947
Acknowledgments
The study was supported by the Russian Foundation for Basic Research (grant number 14-04-00173) and the Program of the Russian Academy of Science “Molecular and Cell Biology” (grant number 6.7).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Popova, N.K., Kulikov, A.V., Kondaurova, E.M. et al. Risk Neurogenes for Long-Term Spaceflight: Dopamine and Serotonin Brain System. Mol Neurobiol 51, 1443–1451 (2015). https://doi.org/10.1007/s12035-014-8821-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12035-014-8821-7